Tandlægeselskabet Overgaden I/S: Financial statements 2024
CVR: 31763207
Tandlægeselskabet Overgaden I/S (CVR 31763207) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,145,801 and a net result of DKK 417,925 compared with DKK 305,464 the year before. That is an increase of 2.4% compared with the year before. Equity amounted to DKK 1,654,475. The solvency ratio was 61.8%. The company had 3 employees in the financial year.
- Gross Profit
- 2,145,801 kr.
- Profit/Loss
- 417,925 kr.
- Equity
- 1,654,475 kr.
- Total Assets
- 2,675,878 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2.1 mio. | 418 t. | 1.7 mio. | 3 |
| 2023 | - | 2.1 mio. | 305 t. | 1.6 mio. | 3 |
| 2022 | - | 2.2 mio. | 520 t. | 1.6 mio. | 4 |
| 2021 | - | 2.1 mio. | 176 t. | 1.3 mio. | 4 |
| 2020 | - | 2 mio. | 222 t. | 1.2 mio. | 4 |
How creditworthy is Tandlægeselskabet Overgaden I/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Tandlægeselskabet Overgaden I/S has published its annual report for 2023. Gross profit came to DKK 2,095,721, and the net result was DKK 305,464.
About Tandlægeselskabet Overgaden I/S
Tandlægeselskabet Overgaden I/S is a Danish company of the type Interessentskab based in Børkop, founded in 2008. The company is registered under the industry Tandlægers aktiviteter. The management consists of Helle Søgaard Bøystrup and Mads Edeling. The company has 6 employees. In 2025, the company reported a gross profit of DKK 2,225,756 and a net result of DKK 230,388 compared with DKK 417,925 the year before. Equity amounted to DKK 1,677,212.
